Publications by authors named "Ramon Colomer"

Claim this Profile
C
Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer.
Paloma Galera, Antía Iglesias-Beiroa, Berta Hernández-Marín, Dulce Bañón, Teresa Arangoa, Ramon Colomer

Curr Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancer.
Jacobo Rogado, Fernando Pozo, Kevin Troule, María Pacheco, Magdalena Adrados, Ramon Colomer

Clin Transl Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Ramon Colomer, Blanca González-Farré, Ana Isabel Ballesteros, Vicente Peg, Begoña Bermejo

Clin Transl Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunome profiling in prostate cancer: a guide for clinicians.
Luis San-Jose Manso, Arantzazu Alfranca, Ignacio Moreno-Pérez, María Ruiz-Vico, Clara Velasco, Ramón Colomer

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.
Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora, Fernando Moreno, José Ángel García-Saenz, Ramon Colomer

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Older Age an Independent Prognostic Factor of Survival in Metastatic Colorectal Cancer?
Patricia Toquero, Rebeca Mondéjar, Nuria Romero-Laorden, Elena Méndez, Lucía Castillo, Ramon Colomer

Oncology· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation.
Maria Jose Bueno, Silvana Mouron, Eduardo Caleiras, Mario Martínez, Luis Manso, Ramón Colomer

Clin Transl Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain in Long-Term Cancer Survivors: Prevalence and Impact in a Cohort Composed Mostly of Breast Cancer Survivors.
Concepción Pérez, Dolores Ochoa, Noelia Sánchez, Ana Isabel Ballesteros, Sheila Santidrián, Ramón Colomer

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.
Ramon Colomer, Jesús Miranda, Nuria Romero-Laorden, Javier Hornedo, Lucía González-Cortijo

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.
Rebeca Jimeno, Silvana Mouron, Roberto Salgado, Sherene Loi, Belén Pérez-Mies, Ramón Colomer

Clin Transl Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.
Jacobo Rogado, Fernando Pozo, Kevin Troulé, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Ramon Colomer

Clin Transl Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.
Jacobo Rogado, Fernando Pozo, Kevin Troule, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Ramon Colomer

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair.
Vilma Pacheco-Barcia, Andrés Muñoz, Elena Castro, Ana Isabel Ballesteros, Gloria Marquina, Ramon Colomer

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
Chau Dang, Michael S Ewer, Suzette Delaloge, Jean-Marc Ferrero, Ramon Colomer

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Multidisciplinary consensus on optimizing the detection of NTRK gene alterations in tumours].
Federico Rojo, Ramón Colomer, Fernando López-Ríos, Francisco Bautista, Rosa Álvarez

Rev Esp Patol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emotional Distress in Cancer Patients During the First Wave of the COVID-19 Pandemic.
Patricia Toquero, Carmen Blanco Fernández, María Pilar López Martí, Berta Hernández Marín, E Beatriz Vera Cea, Ramon Colomer

Front Psychol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.
Jacobo Rogado, Nuria Romero-Laorden, José Miguel Sanchez-Torres, Ana María Ramos-Levi, Vilma Pacheco-Barcia, Ramon Colomer

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pharmacological or Genetic Blockade of Endogenous Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells.
Thomas W Grunt, Lisa Lemberger, Ramón Colomer, María Luz López Rodríguez, Renate Wagner

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.
Silvana Mouron, Luis Manso, Eduardo Caleiras, Jose L Rodriguez-Peralto, Oscar M Rueda, Ramon Colomer

Breast Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Antoinette R Tan, Seock-Ah Im, André Mattar, Ramon Colomer, Daniil Stroyakovskii

Lancet Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
Miguel Quintela-Fandino, Esther Holgado, Luis Manso, Serafin Morales, Begoña Bermejo, Ramon Colomer

Breast Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new role for circulating T follicular helper cells in humoral response to anti-PD-1 therapy.
Santiago Sánchez-Alonso, Giulia Setti-Jerez, Montserrat Arroyo, Tathiana Hernández, Mª Inmaculada Martos, Ramon Colomer

J Immunother Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer.
Thomas W Grunt, Astrid Slany, Mariya Semkova, Ramón Colomer, María Luz López-Rodríguez

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When should we order a next generation sequencing test in a patient with cancer?
Ramon Colomer, Rebeca Mondejar, Nuria Romero-Laorden, Arantzazu Alfranca, Francisco Sanchez-Madrid

EClinicalMedicine· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Regulation of Gfi1 in Endocrine-Related Cancers: a Role Regulating Tumor Growth.
Nadia Ashour, Javier C Angulo, Ana González-Corpas, María J Orea, María V T Lobo, Ramón Colomer

Int J Mol Sci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis